Alessandra Chiappori
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Galectin-3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months.
Journal: Clinical and translational allergy
Published: September 13, 2016
Molecular diagnosis and precision medicine in allergy management.
Journal: Clinical chemistry and laboratory medicine
Published: January 06, 2016
Molecular phenotyping and biomarker development: are we on our way towards targeted therapy for severe asthma?
Journal: Expert review of respiratory medicine
Published: November 14, 2015
CD4(+)CD25(high)CD127(-) regulatory T-cells in COPD: smoke and drugs effect.
Journal: The World Allergy Organization journal
Published: August 13, 2015
Biomarkers and severe asthma: a critical appraisal.
Journal: Clinical and molecular allergy : CMA
Published: June 18, 2015
Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients.
Journal: International journal of immunopathology and pharmacology
Published: June 16, 2012
Salbutamol: how does it enter smooth muscle cells?
Journal: International journal of immunopathology and pharmacology
Published: June 16, 2012
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells.
Journal: Immunology letters
Published: April 23, 2012
COPD treatment: real life and experimental effects on peripheral NK cells, their receptors expression and their IFN-γ secretion.
Journal: Pulmonary pharmacology & therapeutics
Published: April 19, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026